Lifetime cost of stroke subtypes in Australia: findings from the North East Melbourne stroke incidence study (NEMESIS)

Dewey, Helen M., Thrift, Amanda G., Mihalopoulos, Cathy, Carter, Rob, Macdonell, Richard A. L., McNeil, John J. and Donnan, Geoffrey A. 2003, Lifetime cost of stroke subtypes in Australia: findings from the North East Melbourne stroke incidence study (NEMESIS), Stroke, vol. 34, no. 10, pp. 2502-2507, doi: 10.1161/01.STR.0000091395.85357.09.

Attached Files
Name Description MIMEType Size Downloads

Title Lifetime cost of stroke subtypes in Australia: findings from the North East Melbourne stroke incidence study (NEMESIS)
Author(s) Dewey, Helen M.
Thrift, Amanda G.
Mihalopoulos, CathyORCID iD for Mihalopoulos, Cathy
Carter, RobORCID iD for Carter, Rob
Macdonell, Richard A. L.
McNeil, John J.
Donnan, Geoffrey A.
Journal name Stroke
Volume number 34
Issue number 10
Start page 2502
End page 2507
Publisher Lippincott Williams & Wilkins
Place of publication Philadelphia, Pa.
Publication date 2003-10
ISSN 0039-2499
Keyword(s) Australia
costs and cost analysis
stroke classification
Summary Background and Purpose-: Little is known about any variations in resource use and costs of care between stroke subtypes, especially nonhospital costs. The purpose of this study was to describe the patterns of resource use and to estimate the first-year and lifetime costs for stroke subtypes.

Methods-: A cost-of-illness model was used to estimate the total first-year costs and lifetime costs of stroke subtypes for all strokes (subarachnoid hemorrhages excluded) that occurred in Australia during 1997. For each subtype, average cost per case during the first year and the present value of average cost per case over a lifetime were calculated. Resource use data obtained in the North East Melbourne Stroke Incidence Study (NEMESIS) were used.

Results-: The present value of total lifetime costs for all strokes was Aus $1.3 billion (US $985 million). Total lifetime costs were greatest for ischemic stroke (72%; Aus $936.8 million; US $709.7 million), followed by intracerebral hemorrhage (26%; Aus $334.5 million; US $253.4 million) and unclassified stroke (2%; Aus $30 million; US $22.7 million). The average cost per case during the first year was greatest for total anterior circulation infarction (Aus $28 266). Over a lifetime, the present value of average costs was greatest for intracerebral hemorrhage (Aus $73 542), followed by total anterior circulation infarction (Aus $53 020), partial anterior circulation infarction (Aus $50 692), posterior circulation infarction (Aus $37 270), lacunar infarction (Aus $34 470), and unclassified stroke (Aus $12 031).

Conclusions-: First-year and lifetime costs vary considerably between stroke subtypes. Variation in average length of total hospital stay is the main explanation for differences in first-year costs.
Language eng
DOI 10.1161/01.STR.0000091395.85357.09
Field of Research 140208 Health Economics
HERDC Research category C1.1 Refereed article in a scholarly journal
Copyright notice ©2003, American Heart Association, Inc.
Persistent URL

Document type: Journal Article
Collections: Faculty of Health
School of Health and Social Development
Connect to link resolver
Unless expressly stated otherwise, the copyright for items in DRO is owned by the author, with all rights reserved.

Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 67 times in TR Web of Science
Scopus Citation Count Cited 74 times in Scopus
Google Scholar Search Google Scholar
Access Statistics: 1056 Abstract Views, 0 File Downloads  -  Detailed Statistics
Created: Thu, 31 Jul 2008, 10:41:29 EST

Every reasonable effort has been made to ensure that permission has been obtained for items included in DRO. If you believe that your rights have been infringed by this repository, please contact